Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Grant or award SVP, Finance and CAO acquired 26,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 32,000 shares (grant or award)
  3. 4 Grant or award President & CEO acquired 89,000 shares (grant or award)
  4. 4 Open-market sale VP, Finance and CAO sold 7,345 shares at $6.52 ($47,889)
  5. 4 Open-market sale Chief Medical Officer sold 1,605 shares at $7.34 ($11,781)
  6. 4 Open-market sale President & CEO sold 3,208 shares at $7.34 ($23,547)
  7. 4 Open-market sale VP, Finance and CAO sold 466 shares at $7.34 ($3,420)
  8. 4 Open-market sale Chief Financial Officer sold 887 shares at $7.34 ($6,511)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Chief Medical Officer acquired 12,829 shares (option exercise)
  16. 4 Open-market sale VP, Finance and CAO sold 482 shares at $11.07 ($5,336)
  17. 4 Open-market sale Chief Medical Officer sold 1,617 shares at $11.07 ($17,901)
  18. 4 Open-market sale Chief Financial Officer sold 893 shares at $11.07 ($9,886)
  19. 4 Open-market sale President & CEO sold 3,232 shares at $11.07 ($35,779)
  20. 4 Exercise or conversion Chief Medical Officer acquired 46,474 shares (option exercise)

Page 6 of 11 · 213 filings